Literature DB >> 9270991

Invasive pneumococcal disease in the immunocompromised host.

E N Janoff1, J B Rubins.   

Abstract

A normal constituent of the human upper respiratory flora, Streptococcus pneumoniae also produces respiratory tract infections that progress to invasive disease at high rates in specific risk groups. The individual factors that contribute to the development of invasive pneumococcal disease in this distinct minority of persons, include immune (both specific and innate), genetic, and environmental elements. Specific defects in host responses may involve age, deficiencies in levels of antibodies and complement factors, and splenic dysfunction. Combinations of these immune defects contribute to the increased rates of invasive pneumococcal disease in patients with sickle cell disease, nephrotic syndrome, neoplasms, and underlying medical conditions such as diabetes and alcoholic liver disease. The number of risk factors are greatest and the rates of invasive disease are highest in patients with HIV-1 infection, which has emerged as a major risk factor for serious S. pneumoniae infection worldwide.

Entities:  

Mesh:

Year:  1997        PMID: 9270991     DOI: 10.1089/mdr.1997.3.215

Source DB:  PubMed          Journal:  Microb Drug Resist        ISSN: 1076-6294            Impact factor:   3.431


  15 in total

1.  Pneumolysin-induced complement depletion during experimental pneumococcal bacteremia.

Authors:  R B Alcantara; L C Preheim; M J Gentry-Nielsen
Journal:  Infect Immun       Date:  2001-06       Impact factor: 3.441

2.  Essential PcsB putative peptidoglycan hydrolase interacts with the essential FtsXSpn cell division protein in Streptococcus pneumoniae D39.

Authors:  Lok-To Sham; Skye M Barendt; Kimberly E Kopecky; Malcolm E Winkler
Journal:  Proc Natl Acad Sci U S A       Date:  2011-10-17       Impact factor: 11.205

3.  Genome sequence of Avery's virulent serotype 2 strain D39 of Streptococcus pneumoniae and comparison with that of unencapsulated laboratory strain R6.

Authors:  Joel A Lanie; Wai-Leung Ng; Krystyna M Kazmierczak; Tiffany M Andrzejewski; Tanja M Davidsen; Kyle J Wayne; Hervé Tettelin; John I Glass; Malcolm E Winkler
Journal:  J Bacteriol       Date:  2006-10-13       Impact factor: 3.490

4.  Tuberculosis in children with sickle cell anaemia: a retrospective study in French tertiary care centres.

Authors:  Nina Droz; Agathe De Lauzanne; Laurent Holvoet; Florence Missud; Malika Benkerrou; Valentine Brousse; Marie-Hélène Odièvre; Albert Faye; Berengere Koehl
Journal:  Eur J Pediatr       Date:  2017-04-11       Impact factor: 3.183

5.  A trial of a 7-valent pneumococcal conjugate vaccine in HIV-infected adults.

Authors:  Neil French; Stephen B Gordon; Thandie Mwalukomo; Sarah A White; Gershom Mwafulirwa; Herbert Longwe; Martin Mwaiponya; Eduard E Zijlstra; Malcolm E Molyneux; Charles F Gilks
Journal:  Malawi Med J       Date:  2016-09       Impact factor: 0.875

6.  Using Inverse Problem Methods with Surveillance Data in Pneumococcal Vaccination.

Authors:  Karyn L Sutton; H T Banks; Carlos Castillo-Chavez
Journal:  Math Comput Model       Date:  2010-03-01

7.  Regulation of the pspA virulence factor and essential pcsB murein biosynthetic genes by the phosphorylated VicR (YycF) response regulator in Streptococcus pneumoniae.

Authors:  Wai-Leung Ng; Ho-Ching Tiffany Tsui; Malcolm E Winkler
Journal:  J Bacteriol       Date:  2005-11       Impact factor: 3.490

8.  The Role of Dendritic Cells in S. pneumoniae Transport to Follicular Dendritic Cells.

Authors:  Balthasar A Heesters; Michael C Carroll
Journal:  Cell Rep       Date:  2016-09-20       Impact factor: 9.423

Review 9.  Risks for infection in patients with asthma (or other atopic conditions): is asthma more than a chronic airway disease?

Authors:  Young J Juhn
Journal:  J Allergy Clin Immunol       Date:  2014-08       Impact factor: 10.793

10.  Association of kynurenine aminotransferase II gene C401T polymorphism with immune response in patients with meningitis.

Authors:  Fladjule Rejane Soares de Souza; Fabrícia Lima Fontes; Thayse Azevedo da Silva; Leonam Gomes Coutinho; Stephen L Leib; Lucymara Fassarella Agnez-Lima
Journal:  BMC Med Genet       Date:  2011-04-07       Impact factor: 2.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.